Literature DB >> 35120710

Parsing the Network Mechanisms of Electroconvulsive Therapy.

Amber M Leaver1, Randall Espinoza2, Benjamin Wade3, Katherine L Narr4.   

Abstract

Electroconvulsive therapy (ECT) is one of the oldest and most effective forms of neurostimulation, wherein electrical current is used to elicit brief, generalized seizures under general anesthesia. When electrodes are positioned to target frontotemporal cortex, ECT is arguably the most effective treatment for severe major depression, with response rates and times superior to other available antidepressant therapies. Neuroimaging research has been pivotal in improving the field's mechanistic understanding of ECT, with a growing number of magnetic resonance imaging studies demonstrating hippocampal plasticity after ECT, in line with evidence of upregulated neurotrophic processes in the hippocampus in animal models. However, the precise roles of the hippocampus and other brain regions in antidepressant response to ECT remain unclear. Seizure physiology may also play a role in antidepressant response to ECT, as indicated by early positron emission tomography, single-photon emission computed tomography, and electroencephalography research and corroborated by recent magnetic resonance imaging studies. In this review, we discuss the evidence supporting neuroplasticity in the hippocampus and other brain regions during and after ECT, and their associations with antidepressant response. We also offer a mechanistic, circuit-level model that proposes that core mechanisms of antidepressant response to ECT involve thalamocortical and cerebellar networks that are active during seizure generalization and termination over repeated ECT sessions, and their interactions with corticolimbic circuits that are dysfunctional prior to treatment and targeted with the electrical stimulus.
Copyright © 2021 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antidepressant; Depression; Electroconvulsive therapy; MRI; Neuroimaging; Seizure

Mesh:

Substances:

Year:  2021        PMID: 35120710      PMCID: PMC9196257          DOI: 10.1016/j.biopsych.2021.11.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   12.810


  144 in total

1.  Acute effect of electroconvulsive therapy on brain perfusion assessed by Tc99m-hexamethylpropyleneamineoxim and single photon emission computed tomography.

Authors:  M Bajc; V Medved; M Basic; N Topuzovic; D Babic; D Ivancevic
Journal:  Acta Psychiatr Scand       Date:  1989-11       Impact factor: 6.392

2.  A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.

Authors:  H A Sackeim; J Prudic; D P Devanand; M S Nobler; S H Lisanby; S Peyser; L Fitzsimons; B J Moody; J Clark
Journal:  Arch Gen Psychiatry       Date:  2000-05

3.  Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression.

Authors:  Krzysztof Gbyl; Egill Rostrup; Jayachandra Mitta Raghava; Carsten Andersen; Raben Rosenberg; Henrik Bo Wiberg Larsson; Poul Videbech
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-28       Impact factor: 5.067

Review 4.  What was learned: studies by the consortium for research in ECT (CORE) 1997-2011.

Authors:  M Fink
Journal:  Acta Psychiatr Scand       Date:  2014-02-12       Impact factor: 6.392

5.  Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy.

Authors:  Laurie M McCormick; Laura L Boles Ponto; Ron K Pierson; Hans J Johnson; Vincent Magnotta; Michael C Brumm
Journal:  J ECT       Date:  2007-12       Impact factor: 3.635

6.  Selective frontal, parietal, and temporal networks in generalized seizures.

Authors:  Hal Blumenfeld; Michael Westerveld; Robert B Ostroff; Susan D Vanderhill; Jason Freeman; Alexandro Necochea; Paula Uranga; Tasha Tanhehco; Arien Smith; John P Seibyl; Rik Stokking; Colin Studholme; Susan S Spencer; I George Zubal
Journal:  Neuroimage       Date:  2003-08       Impact factor: 6.556

7.  Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.

Authors:  Brisa Fernandes; Clarissa S Gama; Rafael Massuda; Mariana Torres; Daniel Camargo; Mauricio Kunz; Paulo Silva Belmonte-de-Abreu; Flávio Kapczinski; Marcelo Pio de Almeida Fleck; Maria Inês Lobato
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

8.  Characterization of hippocampal subfields using ex vivo MRI and histology data: Lessons for in vivo segmentation.

Authors:  Robin de Flores; David Berron; Song-Lin Ding; Ranjit Ittyerah; John B Pluta; Long Xie; Daniel H Adler; John L Robinson; Theresa Schuck; John Q Trojanowski; Murray Grossman; Weixia Liu; Stephen Pickup; Sandhitsu R Das; David A Wolk; Paul A Yushkevich; Laura E M Wisse
Journal:  Hippocampus       Date:  2019-11-01       Impact factor: 3.899

9.  Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression.

Authors:  H Lyden; R T Espinoza; T Pirnia; K Clark; S H Joshi; A M Leaver; R P Woods; K L Narr
Journal:  Transl Psychiatry       Date:  2014-04-08       Impact factor: 6.222

10.  Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study.

Authors:  M Cano; I Martínez-Zalacaín; Á Bernabéu-Sanz; O Contreras-Rodríguez; R Hernández-Ribas; E Via; A de Arriba-Arnau; V Gálvez; M Urretavizcaya; J Pujol; J M Menchón; N Cardoner; C Soriano-Mas
Journal:  Transl Psychiatry       Date:  2017-02-07       Impact factor: 6.222

View more
  1 in total

1.  Social defeat drives hyperexcitation of the piriform cortex to induce learning and memory impairment but not mood-related disorders in mice.

Authors:  Hanjie Wang; Fang Li; Xuefeng Zheng; Lianghui Meng; Meiying Chen; Yuqing Hui; Yifei Li; Keman Xie; Jifeng Zhang; Guoqing Guo
Journal:  Transl Psychiatry       Date:  2022-09-10       Impact factor: 7.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.